IRIS
LASAGNA, ANGIOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.301
AS - Asia 973
EU - Europa 796
SA - Sud America 175
AF - Africa 92
OC - Oceania 2
Totale 3.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.265
SG - Singapore 292
CN - Cina 237
IT - Italia 181
HK - Hong Kong 149
VN - Vietnam 139
RU - Federazione Russa 135
BR - Brasile 120
DE - Germania 103
IE - Irlanda 99
FI - Finlandia 72
FR - Francia 61
ZA - Sudafrica 60
IN - India 46
GB - Regno Unito 44
AR - Argentina 17
CA - Canada 17
BD - Bangladesh 15
TR - Turchia 15
ES - Italia 14
JP - Giappone 14
PL - Polonia 13
AT - Austria 11
VE - Venezuela 11
SE - Svezia 10
IQ - Iraq 9
CO - Colombia 8
MA - Marocco 8
NL - Olanda 8
PK - Pakistan 8
TN - Tunisia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
LT - Lituania 5
MX - Messico 5
PH - Filippine 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
ID - Indonesia 4
JM - Giamaica 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
DM - Dominica 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MZ - Mozambico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YT - Mayotte 1
Totale 3.339
Salva come PNG Salva come JPEG
Città #
San Jose 182
Dallas 178
Singapore 168
Hong Kong 146
Ashburn 128
Chandler 97
Dublin 95
Beijing 85
New York 74
Ho Chi Minh City 59
Johannesburg 53
Munich 53
Boardman 46
Lauterbourg 45
Helsinki 42
Los Angeles 38
Hanoi 32
Shanghai 31
Turku 30
Milan 28
Moscow 22
Redondo Beach 22
Seattle 19
São Paulo 17
Buffalo 15
Orem 15
Pescara 15
Rome 15
Pavia 14
Princeton 14
Chennai 13
Lawrence 13
Tokyo 13
Frankfurt am Main 12
Medford 12
Montreal 11
Santa Clara 11
Warsaw 11
Brooklyn 10
Denver 10
Stockholm 10
The Dalles 10
Baghdad 8
Council Bluffs 8
Düsseldorf 8
Guangzhou 8
Atlanta 7
Nuremberg 7
Vienna 7
Biên Hòa 6
Da Nang 6
Poplar 6
San Francisco 6
Wilmington 6
Boston 5
Cagliari 5
Columbus 5
Delhi 5
Falkenstein 5
Houston 5
Manchester 5
Porto Alegre 5
Tashkent 5
Toronto 5
Amsterdam 4
Ankara 4
Bergamo 4
Buenos Aires 4
Casablanca 4
London 4
Baku 3
Belo Horizonte 3
Bogotá 3
Brussels 3
Cairo 3
Charlotte 3
Desio 3
Dhaka 3
Fortaleza 3
Ha Long 3
Hyderabad 3
Istanbul 3
Lima 3
Luanda 3
Mexico City 3
Nairobi 3
New Delhi 3
Prague 3
Reggio Emilia 3
Rio de Janeiro 3
Tangier 3
Washington 3
Alghero 2
Amman 2
Ann Arbor 2
Bengaluru 2
Betim 2
Biassono 2
Bolu 2
Brasília 2
Totale 2.153
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 148
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 143
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 118
Torque teno virus and cancers: current knowledge 117
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 113
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature 101
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 99
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 99
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 98
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life 95
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 91
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 91
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 91
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 90
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 90
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 89
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 89
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 88
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? 82
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 80
How to use prophylactic G-CSF in the time of COVID-19 75
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 74
Infectious complications and immunotherapy: old pitfalls and new horizons 71
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy 68
The 'hit-and-run' strategy and viral carcinogenesis 66
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 66
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 65
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 65
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 65
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 64
Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey 63
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink 63
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 62
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 61
The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature 60
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review 58
Reply to Y. Ergun et al 58
COVID-19 and breast cancer: May the microbiome be the issue? 58
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) 56
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features 51
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 42
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma 40
Postvaccination immune-mediated hepatitis: what do we really know? 31
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View 7
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness 7
Totale 3.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202284 6 0 1 0 4 1 10 5 2 11 7 37
2022/2023285 22 29 4 26 21 13 0 10 114 2 40 4
2023/2024350 41 51 14 22 29 85 24 31 0 11 14 28
2024/2025834 26 40 45 9 11 60 54 50 186 48 109 196
2025/20261.840 133 113 218 229 251 97 349 125 201 124 0 0
Totale 3.408